BridgeMD
New treatment option for Relapsed/Refractory Ovarian Carcinoma
Official title Study of NTB-928 in R/R OC
ClinicalTrials.gov ID: NCT07690189
What this study is testing
What is NTB-928?
NTB-928 is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for relapsed/refractory ovarian carcinoma.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to determine if NTB-928 can be given safely to adult females with ovarian cancer that has come back (relapsed) or stopped responding to treatment (refractory), how NTB-928 moves through the body, and how the immune system reacts to it. The study will also look for early signs of anti-cancer activity of NTB-928.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Aged 18 years or older
- Have a confirmed diagnosis of ovarian cancer, including high-grade serous, high-grade endometrioid, low-grade serous, or clear cell ovarian cancer...
- Have relapsed or refractory ovarian cancer and have already received standard treatments known to provide benefit; participants are eligible if they...
- Are able to understand the study requirements and are willing to provide written informed consent
- Are willing to use effective birth control during the study and for a period after the last dose of study treatment, if of childbearing potential
You likely can't join if
- Have another active cancer that could interfere with assessment of this study treatment
- Have received another investigational drug or certain cancer treatments within a recent period before starting this study
- Are pregnant or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Lake Success, New York, United States
- Fort Worth, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lake Success, New York, United States; Fort Worth, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.